About Aurélien
Aurelien Chardeau‘s practice focuses on business litigation (including liability issues in industrial risks), criminal law and compliance (anti-corruption and anti-money laundering). He advises major players in the banking and financial sectors (banks, investment service providers, etc.), Life Sciences (health, pharmaceuticals, biotechnology, etc.) and industrial (notably railways). He assists both French and foreign companies (European, Anglo-Saxon and Asian).
Aurelien Chardeau‘s practice focuses on business litigation (including liability issues in industrial risks), criminal law and compliance (anti-corruption and anti-money laundering). He advises major players in the banking and financial sectors (banks, investment service providers, etc.), Life Sciences (health, pharmaceuticals, biotechnology, etc.) and industrial (notably railways). He assists both French and foreign companies (European, Anglo-Saxon and Asian).
Aurelien Chardeau‘s practice focuses on business litigation (including liability issues in industrial risks), criminal law and compliance (anti-corruption and anti-money laundering). He advises major players in the banking and financial sectors (banks, investment service providers, etc.), Life Sciences (health, pharmaceuticals, biotechnology, etc.) and industrial (notably railways). He assists both French and foreign companies (European, Anglo-Saxon and Asian).
Aurelien Chardeau‘s practice focuses on business litigation (including liability issues in industrial risks), criminal law and compliance (anti-corruption and anti-money laundering). He advises major players in the banking and financial sectors (banks, investment service providers, etc.), Life Sciences (health, pharmaceuticals, biotechnology, etc.) and industrial (notably railways). He assists both French and foreign companies (European, Anglo-Saxon and Asian).
Aurelien Chardeau‘s practice focuses on business litigation (including liability issues in industrial risks), criminal law and compliance (anti-corruption and anti-money laundering). He advises major players in the banking and financial sectors (banks, investment service providers, etc.), Life Sciences (health, pharmaceuticals, biotechnology, etc.) and industrial (notably railways). He assists both French and foreign companies (European, Anglo-Saxon and Asian).
